Pravastatin Lactone (CAS 85956-22-5)

Pravastatin Lactone is a metabolite of pravastatin which competitively inhibits HMGCR (hydroxymethylglutaryl-CoA (HMG-CoA) reductase.)Pravastatin lactone, a synthetic derivative of the cholesterol-lowering medication pravastatin, holds significance as an intermediary in the production of pravastatin and other statins. This compound serves as a potent inhibitor of HMG-CoA reductase, the pivotal enzyme in the pathway of cholesterol biosynthesis. Its utility extends to laboratory investigations, where it plays a pivotal role in the exploration of statin impacts on cholesterol metabolism. Moreover, its role encompasses the scrutiny of statins′ mechanisms, as well as their physiological and biochemical influences. Within the realm of pharmaceutical advancement, Pravastatin lactone finds applications in drug exploration and the evaluation of novel statin compounds, assessing their safety and efficacy. The core functionality of pravastatin lactone rests in its inhibition of HMG-CoA reductase, the rate-defining stage in the synthesis of cholesterol. Through this inhibitory action, the compound curtails endogenous cholesterol production, leading to a discernible reduction in serum cholesterol levels.